Gabriela Gruia
Equibles does not estimate personal net worth.
About Gabriela Gruia
Earlier roles on record: Board Member at TScan Therapeutics, Inc. (TCRX) until October 13, 2026. TScan Therapeutics, Inc. reported in an 8-K filed October 16, 2026 that Gabriela Gruia resigned as Board of Directors, effective October 13, 2026. TScan Therapeutics, Inc. reported in an 8-K filed June 16, 2023 that Gabriela Gruia was appointed Nominating and Corporate Governance Committee member, effective June 13, 2023.
“On October 13, 2026, each of Garry Nicholson and Gabriela Gruia, M.D., resigned from the Board of Directors (the "Board") of TScan Therapeutics, Inc. (the "Company") and each committee thereof, in each case effective as of October 13, 2026 (the "Resignations").”
“The Company's Board of Directors appointed Barbara Klencke to the Audit Committee and Gabriela Gruia to the Nominating and Corporate Governance Committee, in each case to replace Ittai Harel, effective as of June 13, 2023.”
Affiliation history
-
2021-01-01–2026-10-13